IMPEDE VTE Score (Myeloma)

IMPEDE VTE Score (Myeloma) - a deterministic tool in Sophie Well's Clinical Scoring & Risk group.

Open the IMPEDE VTE Score (Myeloma) → Runs in your browser. No signup, no tracking.

What this is

IMPEDE VTE Score (Myeloma) is one of 230 deterministic tools in Sophie Well's Clinical Scoring & Risk group. IMPEDE VTE Score (Myeloma) - a deterministic tool in Sophie Well's Clinical Scoring & Risk group.

When to use it

Use this tool when you need a quick, citable reference. Every calculation runs entirely in your browser - no inputs leave your device, no account is required, no AI is involved. The site enforces a strict Content Security Policy and ships no analytics or third-party CDN.

References

Sanfilippo KM, Luo S, Wang TF, et al. Predicting venous thromboembolism in multiple myeloma: development and validation of the IMPEDE VTE score. Am J Hematol. 2019;94(11):1176-1184. Read the source ↗

Worked example: IMPEDE VTE 13 — high VTE risk.

Sophie Well is a reference and educational tool. Not medical, legal, or financial advice. Does not replace clinician judgment, professional billing review, or legal counsel.

Built by Clay Good. Source on GitHub.